10x Genomics, Inc. (TXG) stock
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$56.30+1.31 (+2.38%)
Close on Nov 17, 2026Market cap $7.34BP/E –Yield –
10x Genomics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
10x Genomics's market cap was $7.93B on Nov 11, 2026, against $2.32B a year earlier. Over the last 5 years it ranged from $1.01B to $16.27B, with a median of $4.12B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.93B | +293.3% |
| 2025 | Dec 31, 2025 | $2.02B | +17.2% |
| 2024 | Dec 31, 2024 | $1.72B | -73.6% |
| 2023 | Dec 29, 2023 | $6.50B | +57.7% |
| 2022 | Dec 30, 2022 | $4.12B | -74.7% |
| 2021 | Dec 31, 2021 | $16.27B | +8.8% |
| 2020 | Dec 31, 2020 | $14.95B | +104.0% |
| 2019 | Dec 31, 2019 | $7.33B | – |
See a number that looks wrong?